Centivax, Inc.
South San Francisco, CA
- UEI
- GDKVJMCM5KQ6
- CAGE
- 8LXR4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1 Tower Pl #800, South San Francisco, CA 94080, USA
- Website
- centivax.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| This proposal will advance centi-poult-H5, a broadly protective vaccine to protect poultry from highly pathogenic… | Animal and Plant Health Inspection Service | $1,999,929 | |
| Award of centivax's DHA sbir phase i medical r & d purchase order for "development of human monoclonal antibody… | Medical Command | $249,939 | |
| Development of world's first fully human broad spectrum anti-snake venom - abstract snakebite envenoming poses a… | National Institute of Allergy and Infectious Diseases | $2,987,953 |
About Centivax, Inc.
Centivax, Inc. is a for-profit corporate entity that provides medical research and development services to the U.S. federal government through contract and grant awards. According to the provided background, Centivax specializes in developing monoclonal antibody therapeutics against bacterial and viral pathogens.
Through past prime federal contract awards, Centivax has provided research and development services related to monoclonal antibody therapeutics against Klebsiella pneumonia infection and methicillin-resistant Staphylococcus aureus (MRSA). A 2021 Department of the Army Medical Command contract award funded Centivax's development of a human monoclonal antibody therapeutic against Klebsiella pneumoniae infection. This was a Small Business Innovation Research (SBIR) Program Phase I purchase order contract worth $249,938.69.
Through past prime and sub federal grant awards, Centivax has provided research and development services for monoclonal antibody therapeutics with broad neutralizing capability against snake venoms and sepsis-causing bacterial pathogens. A 2019 National Institutes of Health National Institute of Allergy and Infectious Diseases grant worth $995,570 funded Centivax to develop broadly neutralizing human monoclonal antibodies against toxins found in snake venom. Centivax has also received subawards as a partner to develop monoclonal antibody cocktails targeting MRSA and other bacterial causes of sepsis, including Pseudomonas, Klebsiella and Acinetobacter species. The prime grantees for these sepsis research subawards were The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. and the Naval Medical Research Center.
Quick answers
What is Centivax, Inc.'s UEI?
Centivax, Inc.'s Unique Entity ID (UEI) in SAM.gov is GDKVJMCM5KQ6.
What is Centivax, Inc.'s CAGE code?
Centivax, Inc.'s CAGE code is 8LXR4.
What is Centivax, Inc.'s primary NAICS code?
Centivax, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Centivax, Inc. located?
Centivax, Inc.'s physical address in SAM.gov is 1 Tower Pl #800, South San Francisco, CA 94080, USA.
Is Centivax, Inc. registered in SAM.gov?
Yes. Centivax, Inc.'s SAM.gov registration is active through December 26, 2026.
What is Centivax, Inc.'s most recent federal award?
Centivax, Inc.'s most recent federal grant award is This proposal will advance centi-poult-H5, a broadly protective vaccine to protect poultry from highly pathogenic… (AP26VSSP0000C052), from Animal and Plant Health Inspection Service, on February 2, 2026.
On GovTribe
See Centivax, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors